HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis. (Q39174701)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

title

HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

0 references

0 references

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

author name string

Rabia Nawaz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Sadia Zahid

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Muhammad Idrees

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Shazia Rafique

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Muhammad Shahid

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Ammara Ahad

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Iram Amin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Iqra Almas

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

publication date

11 March 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

published in

Inflammation Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

page(s)

477-486

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

Treatment of hepatitis C as prevention: a modeling case study in Vietnam

5 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Hepatitis C virus entry: possible targets for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Hepatitis C and hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Current and novel therapies for the treatment of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Tumor necrosis factor, other cytokines and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Cytokines in alcoholic and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Immunological and inflammatory functions of the interleukin-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Interleukin-1 and the Pathogenesis of the Acute-Phase Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

IL-1β signaling promotes CNS-intrinsic immune control of West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Inflammasome recognition of influenza virus is essential for adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Cytokine gene polymorphisms and the susceptibility to liver cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Interleukin-1 Inhibits Hepatitis C Virus Subgenomic RNA Replication by Activation of Extracellular Regulated Kinase Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

IL-1 beta attenuates IFN-alpha beta-induced antiviral activity and STAT1 activation in the liver: involvement of proteasome-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Non-alcoholic steatohepatitis: from cell biology to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Interleukin-6 and the acute phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Interleukin-6: from basic science to medicine--40 years in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Enhanced TLR-mediated NF-IL6 dependent gene expression by Trib1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Activation of interleukin-6 gene expression through the NF-kappa B transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Autocrine IL-6 signaling: a key event in tumorigenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

The role of IL-6 and STAT3 in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Negative regulation of cytokine signaling influences inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Interleukin-6 plays a crucial role in the hepatic expression of SOCS3 during acute inflammatory processes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Elevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Tumor necrosis factor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

NF-kappaB as a critical link between inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Biologically active products of stimulated liver macrophages (Kupffer cells).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Inflammatory pathways in liver homeostasis and liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Natural antisense transcript stabilizes inducible nitric oxide synthase messenger RNA in rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Metformin reverses fatty liver disease in obese, leptin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Complexity of the early genetic response to growth factors in mouse fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Transcriptional induction of two genes in human cells by beta interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Isolation of interleukin 2-induced immediate-early genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Interleukin 5 enhances interleukin 2-mediated lymphokine-activated killer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Interferon-gamma acts directly on CD8+ T cells to increase their abundance during virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Natural killer cells in antiviral defense: function and regulation by innate cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Obesity and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

21 January 2018

12 December 2020

Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C

1 reference

https://api.crossref.org/works/10.1007%2FS00011-017-1029-3

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

21 January 2018

1 reference

12 December 2020

Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study

1 reference

12 December 2020

Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia

1 reference

12 December 2020

Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells

1 reference

12 December 2020

The differential effect of food intake and beta-adrenergic stimulation on adipose-derived hormones and cytokines in man.

1 reference

12 December 2020

Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

1 reference

12 December 2020

Increased T-helper interferon-gamma-secreting cells in obese children

1 reference

12 December 2020

Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements

1 reference

12 December 2020

Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1

1 reference

12 December 2020

Inflammasome signaling at the heart of central nervous system pathology

1 reference

12 December 2020

Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A

1 reference

12 December 2020

Tumor necrosis factor-alpha induces c-jun during the regenerative response to liver injury

1 reference

12 December 2020

Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy

1 reference

12 December 2020

Biologic basis for interleukin-1 in disease

1 reference

12 December 2020

Serum levels of alpha-interferon and gamma-interferon in patients with acute and chronic viral hepatitis

1 reference

12 December 2020

Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

1 reference

12 December 2020

Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process

1 reference

12 December 2020

Induction of rat acute-phase proteins by interleukin 6 in vivo

1 reference

12 December 2020

Interleukin-1 and interleukin-1 antagonism

1 reference

12 December 2020

Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid1

1 reference

12 December 2020

Ultrastructural localization of interferon-producing cells in the livers of patients with chronic hepatitis B

1 reference

12 December 2020

Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa

1 reference

12 December 2020

Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression

1 reference

12 December 2020

Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis

1 reference

12 December 2020

Cellular and molecular mechanisms of IFN-γ production induced by IL-2 and IL-12 in a human NK cell line

1 reference

12 December 2020

Spontaneous production of tumour necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection

1 reference

12 December 2020

Transcriptional induction by interferon. New protein(s) determine the extent and length of the induction

1 reference

12 December 2020

Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications

1 reference

12 December 2020

Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism

1 reference

12 December 2020

Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor

1 reference

12 December 2020

Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells

1 reference

12 December 2020

Serum levels of cytokines in chronic liver diseases

1 reference

12 December 2020

IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.

1 reference

12 December 2020

10.1007/S00011-017-1029-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28285394%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference